Chimps Not Needed for Hepatitis C Research
After two decades of dwindling chimpanzee usefulness in infectious disease research, only one disease remained to justify experiments that in humans would be considered unconscionable: Hepatitis C, which kills 340,000 people every year and infects no non-human animal except chimps.
Hepatitis C thus became the main battleground for debates over the ethics and morality of invasive chimp testing, which is permitted nowhere but Gabon and the United States. At least scientifically, that battle now appears settled. In May, the FDA approved two new hepatitis C drugs, both far superior to the only existing treatment and both developed without chimp testing. In December, the Institute of Medicine formally declared chimps unnecessary for hepatitis C drug development, paving the way to treat the closest living relative to humans with humanity.
Bookmarks